Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

ENDRA Life Sciences Inc. - Common Stock (NQ:NDRA)

4.330 UNCHANGED

Streaming Delayed Price Updated: 3:55 PM EDT, Jul 30, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	5
Open	4.330
Bid (Size)	4.200 (200)
Ask (Size)	5.500 (200)
Prev. Close	4.330
Today's Range	4.330 - 4.330
52wk Range	2.960 - 9.850
Shares Outstanding	752,755
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

July 21, 2026

Gainers ENDRA Life Sciences (NASDAQ:NDRA) shares rose 10.8% to $5.94 during Tuesday's after-market session. The market value of their outstanding shares is at $6.2 million. Apimeds Pharmaceuticals...

Via Benzinga

Join the Live Investor Webinar for Noble Africa, the Proposed ASP Isotopes Spin-Out Creating a Public Helium Company

July 17, 2026

From ENDRA Life Sciences Inc.

Via Business Wire

Performance

YTD	+0.9%	+0.9%
1 Month	-18.8%	-18.8%
3 Month	-11.1%	-11.1%
6 Month	+8.3%	+8.3%
1 Year	-20.3%	-20.3%

More News

Join the Live Investor Webinar for Noble Africa, the Proposed ASP Isotopes Spin-Out Creating a Public Helium Company

July 17, 2026

From ASP Isotopes

Via ACCESS Newswire

Halper Sadeh LLC is Investigating Whether BOLD and NDRA are Obtaining Fair Deals for their Shareholders

July 02, 2026

From Halper Sadeh LLC

Via GlobeNewswire

NDRA Stock Alert: Halper Sadeh LLC is Investigating Whether ENDRA Life Sciences Inc. is Obtaining a Fair Price for its Shareholders

June 25, 2026

From Halper Sadeh LLC

Via Business Wire

ASP Isotopes Announces Proposed Merger of Noble Africa with ENDRA Life Sciences and Approximately $50 Million Concurrent Private Placement Financing

June 25, 2026

From ENDRA Life Sciences Inc.

Via Business Wire

ASP Isotopes Announces Proposed Merger of Noble Africa with ENDRA Life Sciences and Approximately $50 Million Concurrent Private Placement Financing

June 25, 2026

From ASP Isotopes Inc.

Via GlobeNewswire

ENDRA Life Sciences (NASDAQ: NDRA) Emerging Diagnostic Infrastructure Catalyst in MASLD as GLP-1 Boom Accelerates – See Other Active Stocks

June 06, 2026

Via AB Newswire

Mojo SmallCap Watch: DGXX, PLUG, MNTS, NDRA, POET Driving AI, GLP-1 and Energy Trends

May 27, 2026

Via AB Newswire

Stocks to Watch: NDRA, SBFM, GOVX, HIVE, ANY Trading Actively NOW!

May 26, 2026

Via AB Newswire

ENDRA Life Sciences (NASDAQ: NDRA) Beats Q1 Expectations, TAEUS® Liver Imaging Advances and Strategic Review Acceleration Fuels Investor Awareness

May 26, 2026

Via AB Newswire

ENDRA Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Update

May 18, 2026

From ENDRA Life Sciences Inc.

Via Business Wire

ENDRA Life Sciences Reports Multi-Site Validation of TAEUS® Liver Device Demonstrating MRI-like Accuracy and Reproducibility

May 14, 2026

From ENDRA Life Sciences Inc.

Via Business Wire

ENDRA Life Sciences (NASDAQ: NDRA) Heats Up as Diagnostic Play Targeting GLP-1 Bottleneck – See Comparison Stocks Inside

April 28, 2026

Via AB Newswire

Small-Cap Medical Stocks: ATAI, CMPS, NDRA, PBM in Focus as U.S. Policy Accelerates Psychedelic Research

April 20, 2026

Via AB Newswire

ENDRA Life Sciences (NASDAQ: NDRA) Targets Billions With TAEUS® Liver Imaging Technology

April 13, 2026

Via AB Newswire

ENDRA Life Sciences (NASDAQ: NDRA) Targets MASLD and GLP-1 Imaging Bottleneck With TAEUS® as Stocks Under $5 Gain Attention Inside

April 07, 2026

Via AB Newswire

ENDRA Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

March 31, 2026

From ENDRA Life Sciences Inc.

Via Business Wire

Discover the top movers in Tuesday's pre-market session. ↗

March 31, 2026

Via Chartmill

Reversal Alert: VTIX, MARA, IBRX, BATL, NDRA, EEIQ Gain Momentum as Multi-Sector Catalysts Build

March 26, 2026

Via AB Newswire

Speculation Alert: PRSO, ITOC, NDRA, BZAI Small-Cap Momentum Builds – More Names Inside

March 25, 2026

Via AB Newswire

ENDRA Life Sciences Initiates Review of Strategic Alternatives to Maximize Shareholder Value

March 25, 2026

From ENDRA Life Sciences Inc.

Via Business Wire

Stocks Under $10: IBRX, VTIX, NDRA, SMX – 2026 Watch Now!

March 19, 2026

Via AB Newswire

ENDRA Life Sciences (NASDAQ: NDRA): Medical Diagnostic Play in the $100B+MASH+GLP-1 Healthcare Boom

March 17, 2026

Via AB Newswire

ENDRA Life Sciences (NASDAQ: NDRA): The GLP-1 Healthcare Boom Offering Tremendous Opportunity Watch HIMS, ANTX, ATAI, PURR Now!

March 09, 2026

Via AB Newswire

Frequently Asked Questions

Is ENDRA Life Sciences Inc. - Common Stock publicly traded?

Yes, ENDRA Life Sciences Inc. - Common Stock is publicly traded.

What exchange does ENDRA Life Sciences Inc. - Common Stock trade on?

ENDRA Life Sciences Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for ENDRA Life Sciences Inc. - Common Stock?

The ticker symbol for ENDRA Life Sciences Inc. - Common Stock is NDRA on the Nasdaq Stock Market

What is the current price of ENDRA Life Sciences Inc. - Common Stock?

The current price of ENDRA Life Sciences Inc. - Common Stock is 4.330

When was ENDRA Life Sciences Inc. - Common Stock last traded?

The last trade of ENDRA Life Sciences Inc. - Common Stock was at 07/30/26 03:55 PM ET

What is the market capitalization of ENDRA Life Sciences Inc. - Common Stock?

The market capitalization of ENDRA Life Sciences Inc. - Common Stock is 3.26M

How many shares of ENDRA Life Sciences Inc. - Common Stock are outstanding?

ENDRA Life Sciences Inc. - Common Stock has 3M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.